APA (7th ed.) Citation

Claassens, D. M., Bergmeijer, T. O., Vos, G. J., Hermanides, R. S., van ’t Hof, A. W., van der Harst, P., . . . ten Berg, J. M. (2021). Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis. Circulation. Cardiovascular interventions, 14(4), e009434. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434

Chicago Style (17th ed.) Citation

Claassens, Daniel M.F., et al. "Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis." Circulation. Cardiovascular Interventions 14, no. 4 (2021): e009434. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434.

MLA (9th ed.) Citation

Claassens, Daniel M.F., et al. "Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis." Circulation. Cardiovascular Interventions, vol. 14, no. 4, 2021, p. e009434, https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434.